Skip to main content

Table 2 Presence and distribution of decision regret across sociodemographic, clinicopathological, and psychological characteristics*

From: Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy

 

Decision regret

 

Yes

No

 

n

%

n

%

p-value

373

10.9

3035

89.1

 

Sociodemographic characteristics

     

Age at survey, mean (SD), y

78.9 (6.3)

 

78.8 (6.5)

 

0.712

Level of education

    

0.196

 Low

113

9.6

1066

90.5

 

 Intermediate

64

11.9

473

88.1

 

 High

49

13.0

328

87.0

 

 Tertiary

96

10.2

844

89.8

 

Partnership

    

0.222

 Yes

277

10.5

2358

89.5

 

 No

51

12.5

356

87.5

 

Children

    

0.744

 Yes

331

11.0

2679

89.0

 

 No

40

10.4

343

89.6

 

Clinicopathological characteristics

Years since RP, mean (SD)

16.8 (3.61)

 

16.4 (3.80)

 

0.080

Positive PC family history

    

0.015

 Yes

171

12.5

1193

87.5

 

 No

202

9.9

1842

90.1

 

Secondary cancer

    

0.274

 Yes

39

9.4

377

90.6

 

 No

334

11.2

2658

88.8

 

PSA at diagnosis, mean (SD), ng/ml

9.7 (10.1)

 

10.6 (12.7)

 

0.893

Organ defined disease at RP

    

0.134

 Yes

279

11.5

2141

88.5

 

 No

94

9.7

871

90.3

 

Lymph node invasion at RP

    

0.469

 Yes

12

9.0

121

91.0

 

 No

360

11.0

2906

89.0

 

Biochemical recurrence

    

< 0.001

 Yes

165

13.3

1074

86.7

 

 No

208

9.6

1961

90.4

 

Current active therapy

    

0.123

 Yes

49

13.3

319

86.7

 

 No

324

10.7

2716

89.3

 

Psychological characteristics and HRQoL

Decision making

    

0.005

 Active

107

11.7

805

88.3

 

 Shared

204

9.7

1890

90.3

 

 Passive

57

15.2

319

84.8

 

HRQoL

    

< 0.001

 < 70

236

14.2

1430

85.8

 

 ≥ 70

129

7.6

1561

92.4

 

PC anxiety

    

< 0.001

 Yes

153

14.1

933

85.9

 

 No

190

8.9

1937

91.1

 

PSA anxiety

    

< 0.001

 Yes

44

22.1

155

77.9

 

 No

308

10.0

2766

90.0

 

Positive screening for clinical depression

    

< 0.001

 Yes

63

22.7

214

77.3

 

 No

277

9.4

2663

90.6

 

Positive screening for clinical anxiety

    

< 0.001

 Yes

43

18.9

185

81.1

 

 No

296

10.0

2675

90.0

 
  1. *Numbers reflect sample sizes (n (%)) except when reported otherwise.
  2. Abbreviations: RP = radical prostatectomy; PSA = prostate specific antigen; PC = prostate cancer; HRQoL = health-related quality of life; SD = standard deviation; IQR = interquartile range.